Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3275678 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL10537448 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL1961599 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL4071466 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL11515636 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Water SCHEMBL26184970 | 0.96 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL8965122 | 0.96 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Hydrochloric Acid SCHEMBL11781908 | 0.96 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Water SCHEMBL31291058 | 0.96 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL29975144 | 0.94 | CDC25A (0.40) | CDC25ATHRBTSHRCTDSP1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363991-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2023-11-16 | — | — | US | claimed |
| EP-4203900-A1 | ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2023-07-05 | — | — | EP | claimed |
| EP-4199887-A1 | ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2023-06-28 | — | — | EP | claimed |
| US-20220401321-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-12-22 | — | — | US | claimed |
| WO-2022251223-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022251228-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2022-12-01 | — | — | WO | claimed |
| EP-3370830-B1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2020-02-05 | — | — | EP | claimed |
| EP-3370830-A1 | ORAL CARE COMPOSITIONS AND METHODS | Colgate-Palmolive Company (US) | 2018-09-12 | — | — | EP | claimed |
| WO-2017100265-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE-PALMOLIVE COMPANY (US) | 2017-06-15 | — | — | WO | claimed |
| EP-2046270-B1 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | COLGATE PALMOLIVE CO (US) | 2017-06-07 | — | — | EP | claimed |
| US-8506698-B2 | Oral compositions and methods | COLGATE-PALMOLIVE COMPANY (US) | 2013-08-13 | — | — | US | claimed |
| US-20110033394-A1 | ORAL COMPOSITIONS AND METHODS | COLGATE-PALMOLIVE COMPANY (US) | 2011-02-10 | — | — | US | claimed |
| EP-2280685-A1 | ORAL COMPOSITIONS COMPRISING SHELLAC WAX AND BLEACHED SHELLAC FOR USE IN STOMATOLOGY AND DENTAL CARE | Colgate-Palmolive Company (US) | 2011-02-09 | — | — | EP | claimed |
| EP-2265242-A1 | HIGH FLUORIDE ION RECOVERY COMPOSITIONS | Colgate-Palmolive Company (US) | 2010-12-29 | — | — | EP | claimed |
| WO-2009124311-A1 | ORAL COMPOSITIONS COMPRISING SHELLAC WAX AND BLEACHED SHELLAC FOR USE IN STOMATOLOGY AND DENTAL CARE | COLGATE-PALMOLIVE COMPANY (US) | 2009-10-08 | — | — | WO | claimed |
| WO-2009117644-A1 | HIGH FLUORIDE ION RECOVERY COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2009-09-24 | — | — | WO | claimed |
| US-20090238777-A1 | High Fluoride Ion Recovery Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2009-09-24 | — | — | US | claimed |
| EP-2046270-A2 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | Colgate-Palmolive Company (US) | 2009-04-15 | — | — | EP | claimed |
| WO-2008005688-A2 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | COLGATE-PALMOLIVE COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080003187-A1 | High fluoride ion oral care composition and method for maintaining anticaries activity | COLGATE-PALMOLIVE COMPANY | 2008-01-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230363991-A1 | Oral Care Compositions | DSC1, SLC6A12, OTC | CDC25A 3980/4885THRB 647/4885TSHR 1621/4885 |
| US-20220401321-A1 | Oral Care Compositions | TUBGCP3, TUBGCP4, TUBGCP2 | CDC25A 4104/4885THRB 1379/4885TSHR 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.